Here, we aimed to investigate whether valsartan protects against LPS-induced ALI through anti-inflammatory and anti-oxidative stress activity and inhibition of mucin MUC5AC secretion, as well as to explore the underlying mechanism using network pharmacology. The gene discussed is MUC5AC; the disease is acute respiratory distress syndrome.